Blog Band - Page 284 of 299

26

Nov 2020

PharmaShots Interview: True Digital Surgery’s Aidan Foley Shares Insight on the Aesculap Aeos Robotic Digital Microscope

In a recent interview with PharmaShots, Aidan Foley, Chairman and Chief Executive Officer of True Digital Surgery shared his insights and highlights on data of the Aesculap Aeos Robotic Digital Microscope. Shots: The robotic…

26

Nov 2020

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it Life sciences companies are putting all of their efforts…

23

Nov 2020

THOUGHTSPOT

Organs on a chip (OOCs) – Transforming Animal Testing

Clinical studies cost money, time, and animal lives. There is an urgent need for alternative ways to model human diseases in-vitro to speed-up the new drug development process. Recently, Indian…

19

Nov 2020

INSIGHTS+

Insights+: The US FDA New Drug Approvals in October 2020

The US FDA has approved 4 NDAs and 1 BLA in Oct 2020, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation…

16

Nov 2020

VIEWPOINTS

PharmaShots Interview: Neurocrine’s Dr. Eiry Roberts Shares Insight on Ongentys (opicapone)

In a recent interview with PharmaShots, Dr. Eiry Roberts, Chief Medical Officer of Neurocrine Biosciences shares her insights and highlights on data of Ongentys. Shots: In a post-hoc, sub-group analysis…

12

Nov 2020

TOP 20

Top 20 Animal Health Companies Based on 2019 Revenue

Healthy animals contribute to the elimination of hunger and sustainable food production. The diseases that affect animal health also affect humans. Tackling them while they are present in animals not…

09

Nov 2020

VIEWPOINTS

PharmaShots Interview: Dicerna’s Doug Fambrough Shares Insight on Nedosiran Data Presented at ASN Week 2020

In a recent interview with PharmaShots, Doug Fambrough, Ph.D., President and CEO of Dicerna shares his insights and highlights on data of Nedosiran presented at ASN Week 2020. Shots: All…

05

Nov 2020

INSIGHTS+

Insights+ Key Biosimilars Events of October 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency During the month of October, Henlius signed two agreements for its biosimilar…

03

Nov 2020

VIEWPOINTS

PharmaShots Interview: Eli Lilly’s Dr. Lotus Mallbris Shares Insights on Mirikizumab

In a recent interview with PharmaShots, Dr. Lotus Mallbris, the Vice President of Immunology Development at Eli Lilly shares her insights and highlights on Mirikizumab. Shots: @52wks. ~60% achieved endoscopic responses (58.5% in…

30

Oct 2020

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – October 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected…

PharmaShots Interview: True Digital Surgery’s Aidan Foley Shares Insight on the Aesculap Aeos Robotic Digital Microscope

Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

Organs on a chip (OOCs) – Transforming Animal Testing

Insights+: The US FDA New Drug Approvals in October 2020

PharmaShots Interview: Neurocrine’s Dr. Eiry Roberts Shares Insight on Ongentys (opicapone)

Top 20 Animal Health Companies Based on 2019 Revenue

PharmaShots Interview: Dicerna’s Doug Fambrough Shares Insight on Nedosiran Data Presented at ASN Week 2020

Insights+ Key Biosimilars Events of October 2020

PharmaShots Interview: Eli Lilly’s Dr. Lotus Mallbris Shares Insights on Mirikizumab

Insights+: COVID-19 Healthcare News Monthly Updates – October 2020

Contact US

OUR INFORMATION

FOLLOW US